Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 2
1976 3
1977 4
1978 4
1979 4
1980 2
1981 3
1982 3
1983 11
1984 7
1985 6
1986 6
1987 13
1988 13
1989 14
1990 16
1991 10
1992 12
1993 24
1994 28
1995 19
1996 28
1997 32
1998 24
1999 34
2000 47
2001 38
2002 40
2003 45
2004 52
2005 67
2006 60
2007 85
2008 91
2009 93
2010 116
2011 113
2012 114
2013 131
2014 159
2015 190
2016 223
2017 261
2018 249
2019 265
2020 278
2021 24
Text availability
Article attribute
Article type
Publication date

Search Results

2,741 results
Results by year
Filters applied: . Clear all
Page 1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Bray F, et al. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. CA Cancer J Clin. 2018. PMID: 30207593 Free article.
In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer
In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of …
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Antoni S, et al. Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28. Eur Urol. 2017. PMID: 27370177 Review.
CONTEXT: Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. ...EVIDENCE ACQUISITION: Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research …
CONTEXT: Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012. ...EVIDENC …
Colon Cancer: Inflammation-Associated Cancer.
Shawki S, Ashburn J, Signs SA, Huang E. Shawki S, et al. Surg Oncol Clin N Am. 2018 Apr;27(2):269-287. doi: 10.1016/j.soc.2017.11.003. Epub 2017 Dec 15. Surg Oncol Clin N Am. 2018. PMID: 29496089 Free PMC article. Review.
Colitis-associated cancer is a relatively rare form of cancer with an unclear pathogenesis. Colitis-associated cancer serves as a prototype of inflammation-associated cancers. Advanced colonoscopic techniques are considered standard of care for surveillanc
Colitis-associated cancer is a relatively rare form of cancer with an unclear pathogenesis. Colitis-associated cancer s …
Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer.
Satyal U, Srivastava A, Abbosh PH. Satyal U, et al. Front Oncol. 2019 Nov 19;9:1266. doi: 10.3389/fonc.2019.01266. eCollection 2019. Front Oncol. 2019. PMID: 31803629 Free PMC article. Review.
With recent advancements in a non-invasive approach to cancer diagnosis and surveillance, the term "liquid biopsy" has gained traction but is currently limited by technological challenges in identifying and isolating circulating tumor cells (CTCs), proteins, cell-fr …
With recent advancements in a non-invasive approach to cancer diagnosis and surveillance, the term "liquid biopsy" has gained …
Overview of Breast Cancer Therapy.
Moo TA, Sanford R, Dang C, Morrow M. Moo TA, et al. PET Clin. 2018 Jul;13(3):339-354. doi: 10.1016/j.cpet.2018.02.006. PET Clin. 2018. PMID: 30100074 Free PMC article. Review.
Breast cancer treatment is multidisciplinary. Most women with early stage breast cancer are candidates for breast-conserving surgery with radiotherapy or mastectomy. ...
Breast cancer treatment is multidisciplinary. Most women with early stage breast cancer are candidates for breast-conserving s …
Tissue-resident memory T cells in tissue homeostasis, persistent infection, and cancer surveillance.
Gebhardt T, Palendira U, Tscharke DC, Bedoui S. Gebhardt T, et al. Immunol Rev. 2018 May;283(1):54-76. doi: 10.1111/imr.12650. Immunol Rev. 2018. PMID: 29664571 Review.
Furthermore, we will discuss accumulating data that emphasize localized T(RM) responses as an important determinant of tissue homeostasis and immune defense in the context of microbiota-immune interactions, persistent infections and cancer surveillance....
Furthermore, we will discuss accumulating data that emphasize localized T(RM) responses as an important determinant of tissue homeostasis an …
[Strengthen the cancer surveillance to promote cancer prevention and control in China].
He J. He J. Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):1-4. doi: 10.3760/cma.j.issn.0253-3766.2018.01.001. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29365410 Review. Chinese.
We reviewed the latest advances on cancer surveillance, prevention and control in our country, which may provide important clues for future cancer control. ...China has formed a comprehensive network on cancer prevention and control. Nationwide populat …
We reviewed the latest advances on cancer surveillance, prevention and control in our country, which may provide important clu …
Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome.
Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman JD. Tak CR, et al. Pediatr Blood Cancer. 2019 May;66(5):e27629. doi: 10.1002/pbc.27629. Epub 2019 Feb 4. Pediatr Blood Cancer. 2019. PMID: 30719841 Free PMC article.
METHODS: A Markov decision analytic model was developed from a third-party payer perspective to estimate cost-effectiveness of routine cancer surveillance over a patient's lifetime. The model consisted of four possible health states: no cancer, cancer, …
METHODS: A Markov decision analytic model was developed from a third-party payer perspective to estimate cost-effectiveness of routine ca
[Cancer Surveillance in Inflammatory Bowel Diseases].
Lissner D, Siegmund B. Lissner D, et al. Dtsch Med Wochenschr. 2019 Jun;144(11):753-756. doi: 10.1055/a-0649-5491. Epub 2019 Jun 4. Dtsch Med Wochenschr. 2019. PMID: 31163475 Review. German.
Patients with ulcerative colitis and Crohn's colitis, especially in the presence of primary sclerosing cholangitis, have an increased risk of developing colorectal cancer due to the longstanding colonic inflammation. Therefore, anti-inflammatory drugs reduce this elevated …
Patients with ulcerative colitis and Crohn's colitis, especially in the presence of primary sclerosing cholangitis, have an increased risk o …
Pancreatic Cancer Surveillance: Who, When, and How.
Dudley B, Brand RE. Dudley B, et al. Curr Treat Options Gastroenterol. 2019 Dec;17(4):681-691. doi: 10.1007/s11938-019-00247-0. Curr Treat Options Gastroenterol. 2019. PMID: 31761968 Review.
PURPOSE OF REVIEW: Individuals who have an increased risk for pancreatic cancer (PC) due to personal or family history may benefit from surveillance of the pancreas to increase the likelihood of early detection. This review explores current indications for PC sur
PURPOSE OF REVIEW: Individuals who have an increased risk for pancreatic cancer (PC) due to personal or family history may benefit fr …
2,741 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback